DK141097C - Analogifremgangsmaade til fremstilling af n-(1-(omega-phenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-carboxylsyreamider eller fysiologisk acceptable salte heraf - Google Patents

Analogifremgangsmaade til fremstilling af n-(1-(omega-phenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-carboxylsyreamider eller fysiologisk acceptable salte heraf

Info

Publication number
DK141097C
DK141097C DK439974A DK439974A DK141097C DK 141097 C DK141097 C DK 141097C DK 439974 A DK439974 A DK 439974A DK 439974 A DK439974 A DK 439974A DK 141097 C DK141097 C DK 141097C
Authority
DK
Denmark
Prior art keywords
acidamids
phenylalkyl
alfa
piperidyl
omega
Prior art date
Application number
DK439974A
Other languages
Danish (da)
English (en)
Other versions
DK439974A (es
DK141097B (da
Inventor
A Langbein
H Merz
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK439974A publication Critical patent/DK439974A/da
Publication of DK141097B publication Critical patent/DK141097B/da
Application granted granted Critical
Publication of DK141097C publication Critical patent/DK141097C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK439974A 1973-08-20 1974-08-16 Analogifremgangsmaade til fremstilling af n-(1-(omega-phenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-carboxylsyreamider eller fysiologisk acceptable salte heraf DK141097C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2341965A DE2341965C3 (de) 1973-08-20 1973-08-20 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen
DE2341965 1973-08-20

Publications (3)

Publication Number Publication Date
DK439974A DK439974A (es) 1975-04-28
DK141097B DK141097B (da) 1980-01-14
DK141097C true DK141097C (da) 1980-08-18

Family

ID=5890196

Family Applications (1)

Application Number Title Priority Date Filing Date
DK439974A DK141097C (da) 1973-08-20 1974-08-16 Analogifremgangsmaade til fremstilling af n-(1-(omega-phenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-carboxylsyreamider eller fysiologisk acceptable salte heraf

Country Status (26)

Country Link
US (1) US3933832A (es)
JP (1) JPS5049285A (es)
AT (2) AT334901B (es)
BE (1) BE818989A (es)
BG (1) BG24669A3 (es)
CA (1) CA1041513A (es)
CH (2) CH603630A5 (es)
CS (2) CS182263B2 (es)
DD (1) DD114260A5 (es)
DE (1) DE2341965C3 (es)
DK (1) DK141097C (es)
ES (2) ES429221A1 (es)
FI (1) FI57749C (es)
FR (1) FR2241314B1 (es)
GB (1) GB1468283A (es)
HU (1) HU167563B (es)
IE (1) IE40511B1 (es)
IL (1) IL45494A (es)
NL (1) NL7410989A (es)
NO (1) NO140594C (es)
PH (1) PH11999A (es)
PL (2) PL91562B1 (es)
RO (2) RO63050A (es)
SE (1) SE402285B (es)
SU (2) SU507229A3 (es)
ZA (1) ZA745306B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191683A (en) * 1975-05-28 1980-03-04 Ciba-Geigy Corporation Derivatives of 4-aminopiperidine as stabilizers for polymers
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
WO2002068409A1 (en) 2001-02-23 2002-09-06 Merck & Co., Inc. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US20040142013A1 (en) * 2001-07-13 2004-07-22 Flow Focusing, Inc. Implantable orthopedic surgical devices with controlled release antimicrobial component
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20060263401A1 (en) * 2001-07-13 2006-11-23 Flow Focusing, Inc. Formulation and Method for Preventing Infection
US7592360B2 (en) * 2003-06-04 2009-09-22 Merck & Co., Inc. 3-fluoro-piperidines as NMDA/NR2B antagonists
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) * 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) * 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
KR101506156B1 (ko) * 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸
AU2008240728B2 (en) * 2007-04-23 2013-01-10 Janssen Pharmaceutica N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
RU2480462C2 (ru) * 2007-04-23 2013-04-27 Янссен Фармацевтика Н.В. Производные пиридина, используемые в качестве быстро диссоциирующихся антагонистов допаминовых рецепторов 2
BRPI0915834A2 (pt) * 2008-07-03 2015-11-03 Janssen Pharmaceutica Nv 6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6
DK2307374T3 (en) * 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1232147B (de) * 1961-04-13 1967-01-12 Bayer Ag Verfahren zur Herstellung von acylierten N-(Alkylaminoalkyl)-aminopyridinen
BE623427A (es) * 1961-10-10
US3141823A (en) * 1962-09-04 1964-07-21 Res Lab Dr C Janssen N V Method for producing analgesia
IL25840A (en) * 1965-07-24 1969-12-31 Bayer Ag Optically active pyridine derivatives and their production

Also Published As

Publication number Publication date
IL45494A (en) 1977-07-31
FR2241314B1 (es) 1977-11-10
AT334900B (de) 1977-02-10
FR2241314A1 (es) 1975-03-21
PL91512B1 (es) 1977-02-28
IL45494A0 (en) 1974-11-29
US3933832A (en) 1976-01-20
RO63050A (es) 1978-05-15
SU507229A3 (ru) 1976-03-15
JPS5049285A (es) 1975-05-01
ATA651274A (de) 1976-06-15
CH603630A5 (es) 1978-08-31
DE2341965B2 (de) 1978-06-01
NO140594B (no) 1979-06-25
IE40511L (en) 1975-02-20
CA1041513A (en) 1978-10-31
ES429234A1 (es) 1976-08-16
SE402285B (sv) 1978-06-26
SE7410540L (es) 1975-02-21
PH11999A (en) 1978-10-06
IE40511B1 (en) 1979-06-20
ZA745306B (en) 1976-04-28
GB1468283A (en) 1977-03-23
CS182263B2 (en) 1978-04-28
CS181767B2 (en) 1978-03-31
FI57749C (fi) 1980-10-10
SU504480A3 (ru) 1976-02-25
AU7248974A (en) 1976-02-19
RO63458A (fr) 1978-06-15
NL7410989A (nl) 1975-02-24
BE818989A (fr) 1975-02-19
FI57749B (fi) 1980-06-30
CH603631A5 (es) 1978-08-31
BG24669A3 (en) 1978-04-12
NO742970L (es) 1975-03-17
DD114260A5 (es) 1975-07-20
DK439974A (es) 1975-04-28
DK141097B (da) 1980-01-14
HU167563B (es) 1975-11-28
PL91562B1 (es) 1977-03-31
NO140594C (no) 1979-10-03
DE2341965C3 (de) 1979-01-25
FI234974A (es) 1975-02-21
AT334901B (de) 1977-02-10
DE2341965A1 (de) 1975-03-06
ATA651374A (de) 1976-06-15
ES429221A1 (es) 1976-08-16

Similar Documents

Publication Publication Date Title
DK141097C (da) Analogifremgangsmaade til fremstilling af n-(1-(omega-phenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-carboxylsyreamider eller fysiologisk acceptable salte heraf
DK149893C (da) Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf
DK131725C (da) Analogifremgangsmade til fremstilling af 2,4-diaminoquinazoliner eller salte deraf
DK143227C (da) Analogifremgangsmaade til fremstilling af substituerede 2,2'-methylendiphenoler eller farmakologisk acceptable salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK138325C (da) Analogifremgangsmaade til fremstilling af n-(methoxymethylfurylmethyl)-6,7-benzomorphaner eller -morphinaner eller syreadditionssalte deraf
DK146592C (da) Analogifremgangsmaade til fremstilling af n-substituerede benzensulfonamider eller syreadditionssalte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK142948C (da) Analogifremgangsmaade til fremstilling af biphenylyl-acetylaminopyridiner eller fysiologisk acceptable salte heraf
DK138855C (da) Analogifremgangsmaade til fremstilling af penicilliner eller ikke-toksiske farmaceutisk acceptable salte deraf
DK144094C (da) Analogifremgangsmaade til fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner eller syreadditionssalte deraf
DK153157C (da) Analogifremgangsmaade til fremstilling af 7-alfa-aminoacyl-3-halogen-cephalosporinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK139679C (da) Analogifremgangsmaade til fremstilling af 1,4-dihydro-2h-isoquinolin-derivater eller fysiologisk acceptable salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK144033C (da) Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf
DK155520C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf
DK138498B (da) Analogifremgangsmåde til fremstilling af antibiotikum A204I-derivater eller fysiologisk acceptable kationiske salte deraf.
DK131639B (da) Fremgangsmåde til fremstilling af 7beta-(D-5-amino-5-carboxyvaleramido)-3-(carbamoyloxymethyl)-7-methoxy-3-cephem-4-carboxylsyre eller pharmaceutisk acceptable salte deraf.
DK151028C (da) Analogifremgangsmaade til fremstilling af 1,3-tiazolo(4,3-a)isokinoliner eller salte deraf
DK132628C (da) Analogifremgangsmade til fremstilling af 1-(2-delta2-imidazolinyl)-2,2-diarylcyclopropaner eller syreadditionssalte deraf
DK143197C (da) Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK144656C (da) Analogifremgangsmaade til fremstilling af alkylphenylbenzopyranopyridiner eller pharmaceutiske acceptable salte deraf
DK137857B (da) Analogifremgangsmåde til fremstilling af 2-amino-1,5-benzodiazocinderivater eller farmaceutisk acceptable salte deraf.
DK133004C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive benzomorphanderivater eller salte deraf